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ABSTRACT
Introduction: Care home residents are at particular risk
from medication errors, and our objective was to
determine the prevalence and potential harm of
prescribing, monitoring, dispensing and administration
errors in UK care homes, and to identify their causes.
Methods: A prospective study of a random sample of
residents within a purposive sample of homes in three
areas. Errors were identified by patient interview, note
review, observation of practice and examination of
dispensed items. Causes were understood by observation
and from theoretically framed interviews with home staff,
doctors and pharmacists. Potential harm from errors was
assessed by expert judgement.
Results: The 256 residents recruited in 55 homes were
taking a mean of 8.0 medicines. One hundred and
seventy-eight (69.5%) of residents had one or more
errors. The mean number per resident was 1.9 errors. The
mean potential harm from prescribing, monitoring,
administration and dispensing errors was 2.6, 3.7, 2.1 and
2.0 (0 = no harm, 10 = death), respectively. Contributing
factors from the 89 interviews included doctors who were
not accessible, did not know the residents and lacked
information in homes when prescribing; home staff’s high
workload, lack of medicines training and drug round
interruptions; lack of team work among home, practice
and pharmacy; inefficient ordering systems; inaccurate
medicine records and prevalence of verbal communica-
tion; and difficult to fill (and check) medication adminis-
tration systems.
Conclusions: That two thirds of residents were exposed
to one or more medication errors is of concern. The will to
improve exists, but there is a lack of overall responsibility.
Action is required from all concerned.
INTRODUCTION
Older people living in care homes are potentially at
greater risk of medication error than most other
groups. They are prescribed multiple medicines and
this, coupled with age-related changes in pharma-
cokinetics and pharmacodynamics, makes them
particularly susceptible to adverse drug events.1 2
Many have some degree of cognitive impairment
that prevents them from being actors in the
detection of errors.3 In addition, the medicines
management system in care homes (described in
box 1) is complex—for example, many residents
receive clinical interventions from multiple
sources; medicines may be dispensed from multiple
sites; and medicines may be dispensed in, and
administered from, one of several different types of
packaging systems known as ‘‘monitored dosage
systems’’ (MDS).
In 2000, a report documenting the extent of
medical error was published and the UK govern-
ment committed to reducing errors4 5; medication
errors were a particular concern. Prescribing has
been found to be suboptimal in UK care homes6 7;
Box 1
Context: Care homes and the English National
Health Service
Care homes may provide 24-hour nursing care
(nursing homes), personal care only (residential
homes) or a combination. They may be owned by
individuals or companies of various sizes, including
large private health providers, charities or by the
local authorities. Care homes are reviewed against
standards by the Care Quality Commission, which is
the independent regulator of health and social care
in England. Each resident is registered with a
general practitioner who provides their medical care
and keeps their medical record. When a patient
transfers from their own home to a care home, they
can elect to keep their general practitioner if he or
she is local.
In England, the National Health Service is delivered
through 152 primary care trusts, which are respon-
sible for a geographical area of the country, for which
they commission healthcare from general practi-
tioners (primary care physicians) who usually work
as part of a group practice, pharmacies and others.
Pharmacies may be owned and run by a single
pharmacist or may be part of a chain; the largest
chains are run by international companies. Homes
usually obtain their regular supply of medicines for all
their residents from one pharmacy.
Repeat medicines are ordered from the GP practice
(usually monthly) by the care home staff using the
previous 28-day medicine administration record or
the repeat medicines slip provided by the GP practice.
Generally the GP practice authorises and prints the
repeat prescriptions and sends them to the care
home for checking. They are then forwarded to the
community pharmacy where they are dispensed and
delivered to the care home with a new 28-day
medicine administration record.
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however, we do not know the prevalence of medication errors in
this setting in the UK. Such studies in the USA have been
undertaken; however, they have often relied on spontaneous
reporting,8 9 which significantly underestimates the prevalence
of error.10 11 A US study of medication administration errors
using direct observation found an error rate of 22% in nursing
homes.12 Gurwitz et al2 found 4.1 preventable adverse drug
events per 100 resident-months in two US long-term care
facilities.
Although previous studies have measured prevalence of
specific types of medication errors, they have not been designed
to look at all types of error and simultaneously understand their
causes. The theory of causation of human error13–15 is widely
used in healthcare and has been used to explain causes of
medication errors previously.16 17 In this study, we wished to
determine the prevalence of all forms of medication errors in
care homes, to assess the potential of these errors for harm and
to establish the underlying causes.
METHODS
Ethical approval was obtained from the Central Office for
Research Ethics Committees.
Selection criteria/participants
We chose to sample a large number of homes and small number
of residents per home. It is generally acknowledged that errors
are a consequence of the systems being used,15 so our sampling
strategy was designed to increase the number of systems of care
observed (homes, general practitioners (GPs) and pharmacies).
Care homes for older people (nursing, residential and mixed)
were sampled in three geographically spread and demographi-
cally diverse areas in the UK (West Yorkshire, Cambridgeshire
and central London) to obtain a varied sample with respect to
ownership, size and type of care provided. For each home we
approached the manager/head office to obtain cooperation and
obtained written consent from care home staff who were
observed. Care home residents on one or more medicines were
randomly selected and included in the study if they provided
written, informed consent. For those lacking capacity, assent
was obtained from the next of kin. Written, informed consent
was obtained from GPs providing a service to the homes, which
included access to their care home records and GP records.
Data collection
We used a mixture of methods. The qualitative work was
ethnographically informed and involved field notes, observation
and semistructured interviews based on Reason and Vincent’s
frameworks.14 15 To help understand the causes of specific errors,
we conducted interviews with the home staff, GP or pharma-
cist. Interviews were taped where possible and transcribed;
otherwise, notes were made that were expanded on after the
interview. Analysis of the causes of errors used Reason’s
framework.14 18
The quantitative work to identify prescribing and monitor-
ing errors was undertaken by clinical pharmacists (one in
each of the three areas) conducting clinical medication
reviews for each randomly selected resident. This process
included review of GP and care home notes and consultation
with the resident and/or staff.1 Dispensing errors were
identified by comparing the prescriptions and medication
administration record sheets with the dispensed medicines.
For each drug, it was noted if it was contained in an MDS or
not, and if so, whether it was in a cassette MDS or blister-
pack MDS. Two drug rounds per resident were observed to
identify administration errors. The definitions and denomi-
nators of the four types of error are described in appendix A.
To ensure inter- and intrarater reliability, we produced a
handbook of definitions and procedures, and research staff
were trained in homes together and met regularly to resolve
difficult cases, which were then added to the handbook. If
any errors were thought to be likely to cause patient harm,
then the pharmacist intervened.
The potential harm of each error was assessed using a valid
and reliable method.19 Each error was individually assessed by a
GP, a consultant old age psychiatrist, a clinical pharmacologist
and two clinical pharmacists, using a validated 10-point scale
(0 = no harm; 10 = death); their mean score was taken as the
harm score for that error.
Statistical analysis
Sample size was calculated to give a precision of +/22% SD
(95% confidence interval (CI)) if the prevalence of prescribing
error was 10%. The estimation was derived from a combina-
tion of simulation and formulas for clustered data, and the
output was a matrix of numbers of homes and number of
patients per home (eg, 100 homes with three patients each
gave a precision of 1.9%; 50 homes with six patients each gave
a precision of 2.04%), allowing us to adapt the sample
dependent on recruitment rates. Statistical analysis was
performed using the software R 2.3 (R project for statistical
computing, www.r-project.org). Statistical ‘‘significance’’ was
predefined at the 5% level. Exact binomial CIs were calculated
for proportions. x2 tests were used to assess differences in error
rates between areas. Generalised estimating equations (library
geepack, V.1.0-10) were used to model patient level odds of
errors, allowing for clustering in homes and using an
independence correlation structure. Multilevel models were
also used to model patient level odds of errors, using the
MLwiN 2.03 software (multilevel models project, University
of Bristol, http://www.cmm.bristol.ac.uk), fitting variance
components at the various levels.
RESULTS
Of those approached, 72% (79/108) of homes, 67% (269/399) of
residents and 61% (54/89) of general practices agreed to take
part. Two hundred and fifty-six residents were recruited from
55 care homes. The majority (38, 69%) of the homes provided
both residential and nursing care (corresponding figures for
residential care only and nursing care only: 12 (22%) and 5
(9%)). Table 1 shows demographic data. The majority of the
residents were women (69%, 177/256) and very old (mean age
85 years). There were slightly more residential care residents
(54%, 139/256) than nursing care residents. Two hundred and
twenty (86%) of the residents were dispensed some of their
medicines in a monitored dosage system. There was a mean of
3.8 (range 1–14) GP practices per care home. There was
considerable variation between areas: in London, the median
was 1 (range 1–3) practice per home; in West Yorkshire, the
median was 5 (range 1–14).
We intended to interview those involved in specific errors,
soon after they had happened. However, many errors (such as
some prescribing errors) had been made some time in the past,
so most interviews with doctors and pharmacists focused more
on problems in general in medicines prescribing, dispensing and
use in care homes. We undertook 59 interviews relating to 66
Original research
342 Qual Saf Health Care 2009;18:341–346. doi:10.1136/qshc.2009.034231
 o
n
 26 M
ay 2018 by guest. Protected by copyright.
http://qualitysafety.bmj.com/
Qual Saf Health Care: first published as 10.1136/qshc.2009.034231 on 7 October 2009. Downloaded from
 
administration errors, 34 dispensing errors, 18 prescribing and 8
monitoring errors. Further general interviews were carried out
with 19 pharmacists and 11 GPs, and observations were carried
out in five pharmacies.
Table 2 details the prevalence and potential harm of errors.
Overall, 178 of 256 residents (69.5%, 95% CI 63.5 to 75.1) had at
least one medication error (prescribing, monitoring, adminis-
tration or dispensing). There was a mean of 1.9 (95% CI 1.64 to
2.17) errors per resident. Appendix B gives examples of errors.
Prescribing and monitoring errors
One hundred residents (39.1%, 95% CI 33.0 to 45.3) had one or
more prescribing errors, totalling 153 prescribing errors, and the
prescribing error rate by opportunity for error was 8.3% (95% CI
7.1 to 9.7) (opportunity for error is an act that can be erroneous;
in this case it would be the prescribing of one medicine or the
monitoring of one). The most common types of prescribing
error, accounting for 87.6% of the total, were categorised as
‘‘incomplete information’’ (37.9% meaning, eg, that no strength
or route was specified when there was more than one option),
‘‘unnecessary drug’’ (23.5%), ‘‘dose/strength error’’ (14.4%) and
‘‘omission’’ (11.8%).
In total, there were 147 residents who were prescribed a
medicine that required monitoring, and 18.4% (27) of these had
an error. There were 32 monitoring errors in the 218 prescribed
items that required monitoring (14.7%). The mean number of
monitoring errors per resident was 0.13 (95% CI 0.08 to 0.17).
There was significant variation between areas, with 75% of
monitoring errors occurring in just one geographical area
(p,0.01). Nearly one third (30.8%) of medicines deemed to
require monitoring in the problem area were not being
monitored. The great majority of monitoring errors (90.6%)
resulted from a failure to request monitoring. The drugs most
commonly associated with monitoring errors were diuretics
(53.1%), ACE inhibitors (15.6%), amiodarone (12.5%) and
levothyroxine (9.4%). The mean harm scores for prescribing
and monitoring errors were 2.6 (range 0.2 to 5.8) and 3.7 (range
2.8 to 5.2), respectively.
The interviews categorised factors thought to contribute to
the errors as the patient, the task, the team and the work
environment. Patient factors related to prescribing errors
Table 1 Demographic data
No of residents approached 399
No of residents consented/assented (%) 269 (67.4)
No of residents excluded 13
Consent given post cut-off 6
Died 4
In hospital 3
No of residents entered into study 256
Cambridgeshire 31
West Yorkshire 121
London 104
Women, no (%) 177 (69.1)
Age (y), mean (range) 85.2 (60–102)
Nursing residents, no (%) 117 (45.7)
Residential residents, no (%) 139 (54.3)
Mean no of medicines per resident (95% CI) 8.0 (7.5 to 8.5)
Median no of medicines per resident (range) 7.5 (1–25)
No of residents using monitored dosing systems (%) 220 (85.9)
Cambridgeshire (%) 23 (74.2)
West Yorkshire (%) 117 (96.7)
London (%) 80 (76.9)
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included that patients were generally home bound and could
not access services external to the home; some patients also
disliked blood tests or taking some medicines. Some patients
were confused and unable to give histories. Task factors related
to lack of usual prescribing technical support, including
computer-based aids and accessing the medical record. There
were problems with practice computers’ failure to prompt
monitoring tests clearly. It could be hard to get blood tests done.
There were many ‘‘team factors’’ as there was little sense of
being a whole team (home, pharmacy and practice staff). The
service offered by GP practices was very variable, from a
dedicated GP making weekly visits, to GPs with no knowledge
of the patient making a home visit when requested. Hospital
out-patient and discharge letters were sometimes unclear,
delayed, missed or not adequately incorporated in the patient
record. When changing between GP practices, patient notes
took up to 4 months to arrive. GPs often expressed concern
about the care home staff, including turnover and staff
shortages. The skills of care home staff were sometimes seen
as low, which several linked to pay.
Medication administration errors
Fifty-seven (22.3%, 95% CI 17.3 to 27.9) residents had a total of
116 administration errors. The mean number of administration
errors per resident was 0.45 (95% CI 0.32 to 0.58) and the
prevalence of administration errors by opportunities for error
was 8.4% (95% CI 7.0 to 10.0). Nearly half (49.1%) of all
administration errors were categorised as ‘‘omissions’’ and just
more than one fifth (21.6%) were ‘‘wrong dose’’. The odds of a
medication administration error occurring were higher in
residential care than in nursing care residents; however, this
just failed to reach statistical significance at the 5% level
(adjusted OR 1.77, 95% CI 0.96 to 3.25, p = 0.063; adjusted for
age, sex and medication delivery system). The higher apparent
risk of administration errors in residential compared with
nursing residents was largely attributable to more ‘‘omissions’’
(38 vs 19) and ‘‘wrong doses’’ (18 vs 7). There was no
statistically significant difference in the administration errors
by the medicine delivery system. The mean harm score was 2.1
(range 0.1–5.8).
Patient factors included many patients’ lack of awareness of
their medicines. In addition, their physical condition could make
it hard to administer medicines properly. Some patients had
fears about medicines, such as feeling they were being poisoned,
and some were consequently aggressive. Finding mobile patients
during the drug round could be a problem. Changing or adding
medicines, such as acute treatment, in the middle of the 4-week
supply cycle could be a problem. Task factors included inability
to find the medicine, failure to order the right quantity of ‘‘as
required medicines’’, the special requirements that some
medicines had (eg, ‘‘take on an empty stomach’’), the difficulty
many staff had in correctly administering inhalers and a lack of
adequate protocols. Individual factors related to the staff
included lack of knowledge about inhalers and the timing of
medicines with respect to food. Team factors included the
medication administration record chart, which should be the
documentary line of communication among GP, home and
pharmacist; these records were often inaccurate.
Communication within the home tended to be verbal. Work
environment factors included homes being hot, airless, having
unpleasant smells, being poorly lit, noisy and short of space.
There were often staffing problems in the morning round
(when most medicines were given and when staff also had most
other tasks). Staff were frequently interrupted and did not have
dedicated time to order medicines. In some homes, 12-hour
shifts were usual.
Dispensing errors
Ninety-four residents (36.7%, 95% CI 30.8 to 42.9) had a total of
187 dispensing errors with a mean of 0.73 (95% CI 0.56 to 0.90)
dispensing errors per resident. The dispensing error rate by
opportunity for error was 9.8% (95% CI 8.5 to 11.2). Labelling
errors were found in 7.3% of dispensed items, content errors in
2.3% and clinical errors in 0.21%. There was a borderline
statistically significant difference in the odds of a dispensing
error according to delivery system (p = 0.056), largely due to the
higher odds with the cassette type monitored dosage systems
(cassette vs blister: adjusted odds ratio, 2.88, 95% CI 1.5 to 5.55,
p = 0.0012), which was associated with more labelling errors.
The mean harm score was 2.0 (range 0.2–6.6).
Task factors included the computer systems used, with
some identifying all interactions rather than the clinically
significant ones. Some monitored dosage systems did not have
the space to fit in all the required warning labels, and they
were tedious and difficult to fill. The similar appearance of
many tablets when removed from their original container was
a potential source of error. The prescription and medication
administration record were often different, so it was unclear
which was correct. Individual factors included staff feeling
hungry, tired or unwell while dispensing monitored dosage
systems. There was lack of knowledge by pharmacy staff of
the care homes’ systems and their need for support. Team
factors overlapped with this—some pharmacists had no
knowledge of the care home and its requirements, relation-
ships were sometimes tense and poor language skills of home
staff were sometimes cited. Some pharmacies had a poor
checking process, and use of locums could be a problem. Work
factors included the pharmacies being seen as being busy and
pressured, with interruptions and distractions (including
noise) and some staff shortages.
Organisational culture
When considering all forms of medication errors, factors relating
to organisational culture (called ‘‘latent failures’’ by Reason20)
were significant. It was clear from the interviews that no one
took responsibility for the whole system. We often saw well-
intentioned people doing their best but in an uncoordinated
way. Communication, written and verbal, was another proble-
matic factor, within and among the home, GP practice and
pharmacy. Consequently, it is difficult to know which
medicines any patient should be having. Management within
each organisation was a factor, particularly when challenged to
deliver a safe service within a tight budget.
DISCUSSION
People in care homes are a frail and vulnerable population at
particular risk from medication errors, and it is a cause for
concern that two thirds of care home residents in this study
were exposed to one or more errors. For each event involving
prescribing, dispensing or administration of a medicine, there
was an 8%–10% chance of an error happening and a 14% chance
of a monitoring error. Safety is a systems issue, and we believe
this is the first study to consider the whole system of
medication use in care homes; our simultaneous collection of
qualitative data has allowed us to understand the causes of error
and suggest solutions.
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The prevalence of prescribing error is similar to that found in
primary care21; administration error prevalence was a little
higher than that in hospital22 (and likely to be better than the
patients’ adherence if in their own home).23 The prevalence of
dispensing errors was three times higher than the rate found in
primary care in the UK,24 although that study excluded MDS.
Our higher rate predominantly reflected one type of MDS that
was difficult to label fully.
Although our study was not primarily designed to identify
the prevalence of harm, we saw several errors, particularly
monitoring errors, which had caused harm or were likely to. In
addition, many errors would reduce the quality of life and
ability to function of residents, such as inadequate treatment of
pain, of bowels and of breathing.
Limitations to our study include that our sample only
contained those willing to be studied (although the acceptance
rate of homes was high) and that our home sampling was not
random. Judgement of the cause of error was sometimes
difficult as there could be conflicting sources of evidence or a
lack of evidence; hence, judgements sometimes retained an
element of subjectivity. Observation may theoretically have
affected the prevalence of administration error, although
routine observation has been found to have no effect.11 Staff
interviewed will have given accounts affected by hindsight bias;
hence, imputations of causality are speculative.
What can be done, and who should do it? As our study
shows, there are currently many and varied subsystems that are
not being seen in an integrated way. There is now the
opportunity for a systems approach to the whole. Since 2008,
chief pharmacists of provider organisations and commissioners
in England should have the lead role in ensuring safe medication
practices are embedded in patient care25; a significant and
pressing agenda for them. An additional system-based solution
relates to several of the communication and records problems
observed—we would hope these would be ameliorated by
programmes in the National Health Service’s information
technology programme (NPfIT), such as the Summary Care
Record (a brief GP record which can be accessed by others),
GP2GP (electronic transfer of patients’ notes between GPs) and
the Electronic Prescription Service (electronic transfer of
primary care prescriptions). The final system issue is that most
primary care is based on patients going to centres of care rather
than the other way around. Primary care services that are based
on care going to patients need to be commissioned, in order not
to disadvantage the home bound.
We suggest the idea of a lead (not sole) GP for each home
should be explored. This role would need protected time and
associated funding. In addition to caring for patients, they
should liaise with other GPs and have responsibility to ensure,
possibly by commissioning services, that patients on riskier
medicines are appropriately monitored and that all patients’
medication is regularly reviewed by a pharmacist.
Consideration should be given to having one person with
overall responsibility for medicines use in one or more care
homes. Many pharmacists have the skills and knowledge to
undertake this role, and such developments are described in the
UK government’s recent proposals for making best use of
pharmacists’ expertise.25
Pharmacists supplying homes should ideally know the home,
its ways and needs, so that ordering and supply match the
home’s (and patients’) needs. The widespread use of MDS unit
dose systems, requiring millions of tablets to be repackaged each
week, is a vast, unfunded undertaking. It imposes demands on
home and pharmacy alike, yet its contribution to safety is
unclear and some commissioners discourage its use. The use of
MDS drives efficiencies of scale, such as large centralised
repackaging units, which in turn leads to the dispensary
becoming remote from the customers (home and patient).
Research into the effectiveness of MDS is urgently required.
Within homes the use and accuracy of the medication
administration record requires constant review. The lack of
protocols and adequate staff training remains an issue. Drug
rounds are very busy, and often interrupted in the morning, and
some medicines should be prescribed for different times to ease
this. The commonest administration errors were omissions
because the drug was not available, so omissions need to be
monitored and ordering, particularly of ‘‘as required’’ medicines,
needs to be improved.
We were very impressed by the proportion of homes
participating in a study, which was potentially very threatening
to them. Several care home managers have told us that patient
harm from medication error is their greatest fear and that up to
half of staff time can be spent on medication related activities.
Given this motivation and resource, we are hopeful of change.
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APPENDIX A: ERROR DEFINITIONS
Prescribing errors were identified and classified according to the definition developed
by Dean et al26 as ‘‘A prescribing decision or prescription-writing process that results in
an unintentional, significant: reduction in the probability of treatment being timely and
effective; or increase in the risk of harm, when compared with generally accepted
practice’’. The number of opportunities for error (denominator) was the number of
prescription items written, plus any omissions. The three pharmacists worked to a
common detailed protocol when reviewing the residents and their medicines, were
trained together at the start of the study and had regular review meetings to ensure
consistency.
Monitoring errors were identified according to the definition developed and validated
by Alldred et al 27 as ‘‘A monitoring error occurs when a prescribed medicine is not
monitored in the way which would be considered acceptable in routine general
practice. It includes the absence of tests being carried out at the frequency listed, with
a tolerance of +50%. This means—for example, that if a medicine requires liver
function tests at three monthly intervals, an error would occur if a test was not
conducted within 18 weeks’’. The number of opportunities for error (denominator) was
the number of prescribed items that required monitoring, according to the validated
criteria.
The definition of a dispensing error developed by Beso et al28 was adopted. A
dispensing error was defined as ‘‘One or more deviations from an interpretable written
prescription or medication order, including written modifications to the prescription
made by a pharmacist following contact with the prescriber’’. Dispensing errors were
identified and classified by the clinical pharmacists by comparing the prescriptions and
medicine administration record sheets with the dispensed medicines. The number of
opportunities for error (denominator) was the number of prescription items dispensed
or omitted.
The clinical pharmacists observed two drug rounds per resident to identify and classify
medication administration errors as defined using previous work by Allan and Barker29
and Dean and Barber11 as ‘‘any deviation between the medication prescribed and that
administered’’. The number of opportunities for error (denominator) was the number of
doses given, plus any doses that should have been given but were omitted.
APPENDIX B: EXAMPLES OF ERRORS
Case 1: Prescribing error
Tramadol capsules 50 mg prescribed ‘‘one to be taken up to four times a day’’ for
chronic foot pain, resident also taking warfarin for long-term DVT prophylaxis
(Tramadol can enhance the effect of warfarin). International normalised ratio checked
regularly with erratic results ranging from 0.9 to 4.5 (mean harm score 5.8).
Case 2: Prescribing error
Donepezil 10-mg tablets prescribed ‘‘one daily’’ for dementia. Following a review from
hospital specialist, a letter to the GP indicated Aricept (brand name for donepezil)
should be stopped. The donepezil had not been discontinued by the GP and there was
no indication in the medical notes that the continuation was deliberate (mean harm
score 1.8).
Case 3: Monitoring error
Lisinopril 5-mg tablets prescribed ‘‘one daily’’ for hypertension for a resident with an
estimated creatinine clearance of 19 ml/min. A potassium level had been checked
1 year ago and had revealed a high potassium level 5.8 mmol/l (range 3.5–5 mmol/l):
no action had been taken (mean harm score 5.8).
Case 4: Monitoring error
Amiodarone 200-mg tablets prescribed ‘‘one daily’’ for atrial fibrillation. Thyroid
function tests were last checked 9 months ago, when thyroid stimulating hormone
was 12.9 mlU/l (range 0.3–5.5 mlU/l) and thyroxine was 18 nmol/l (range 50–
151 nmol/l), and no action had been taken (mean harm score 5.8).
Case 5: Medication administration error
Bendroflumethiazide 2.5-mg tablets prescribed ‘‘one each morning’’ for hypertension.
This was discontinued due to low serum sodium of 127 mmol/l (range 135–
145 mmol/l); however, it remained on the current medication administration record
when the next monthly drug supply was made and hence continued to be
administered (mean harm score 4.6).
Case 6: Dispensing error
Aspirin enteric-coated 75 mg tablets dispensed instead of zopiclone 7.5 mg tablets as
a 7-day supply in a cassette dispensing system (mean harm score 5.0).
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